therapeutic 1,246 words KG: ent-dise-bfd8f32d 2026-03-24
kind:therapeuticsection:therapeuticsstate:publishedcbs-pspepigenetic-editing
Contents

Epigenetic Editing and CRISPR Approaches in CBS/PSP

💊 Therapeutic Info
NameEpigenetic Editing and CRISPR Approaches in CBS/PSP
SummaryComprehensive coverage of epigenetic editing technologies including dCas9-DNA methyltransferases, histone modification editing, CRISPRa/CRISPRi for tau pathology, and NET assessment for corticobasal syndrome and progressive supranuclear palsy

Knowledge Graph

Related Hypotheses (30)

Purinergic Signaling Polarization Control
Score: 0.55
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Epigenetic Memory Reprogramming for Alzheimer's Disease
Score: 0.47
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46

Related Analyses (19)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
What delivery mechanisms can achieve therapeutically relevan
drug delivery · failed

Related Experiments (18)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40

See Also (15)

OSK Reprogramming and Yamanaka Factors in Neurodegenera
mechanism · Pages share 5 hypotheses
A Phase 3, Randomised, Double-blinded, Placebo-controll
clinical · Pages share 5 hypotheses
Synaptic Therapy Alzheimer's Research Trial (START): A
clinical · Pages share 5 hypotheses
ALS Therapeutic Landscape — Programs by Phase and Modal
disease · Pages share 4 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses